In this webinar, our 2 key speakers, Luc Aerts ( Heading the Solid State and Material Science group at UCB Pharma) and Mehrdad Pasha ( Powder Expert at UCB Pharma) , covered a holistic overview of different stages of small molecule drug development, specifically focusing on physical and physico-chemical aspects that play a key role during the development of a drug products.
While chemical properties like assay, impurities and their possibly toxic nature are evidently of utmost importance for drug efficacy and safety, some commonly less known aspects of drug development are discussed.
It illustrated how the solid state of an active compound has a direct impact on its stability and bioavailability as well as the impact of good understanding of the physical properties of the ingredients, used in the formulation, on performance of powder processes and drug products in the patients.
ManpowerGroup® (NYSE: MAN), the leading global workforce solutions company, helps organizations transform in a fast-changing world of work by sourcing, assessing, developing and managing the talent that enables them to win. We develop innovative solutions for hundreds of thousands of organizations every year, providing them with skilled talent while finding meaningful, sustainable employment for millions of people across a wide range of industries and skills. Our expert family of brands – Manpower®, Experis®, and Talent Solutions – creates substantially more value for candidates and clients across 80 countries and territories and has done so for 70 years.
© 2024 ManpowerGroup All Rights Reserved.
Terms of Use | Privacy Policy | Cookies statement | MyGDPR Rights